共 50 条
- [21] Comparing ceftolozane/tazobactam versus piperacillin/tazobactam for the initial empiric therapy of urinary tract infections: A retrospective comparative studyJOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (01) : 12 - 16Nakagawa, TomomiShigehara, KazuyoshiShinzawa, ReiYaegashi, HiroshiKawaguchi, ShoheiNohara, TakahiroIzumi, KoujiMizokami, Atsushi
- [22] Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trialJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (07) : 2014 - 2021Huntington, Jennifer A.Sakoulas, GeorgeUmeh, ObiamiweCloutier, Daniel J.Steenbergen, Judith N.Bliss, CalebGoldstein, Ellie J. C.
- [23] The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infectionJOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (02) : 104 - 110Arakawa, SoichiKawahara, KazuyaKawahara, MotoshiYasuda, MitsuruFujimoto, GoSato, AsakoYokokawa, RurikoYoshinari, TomokoRhee, Elizabeth G.Aoyama, Norihiro
- [24] Impact of Renal Function on the Pharmacokinetics and Safety of Ceftolozane-TazobactamANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2249 - 2255Wooley, MyraMiller, BenjaminKrishna, GopalHershberger, EllieChandorkar, Gurudatt
- [25] In Vitro Susceptibility of Ceftolozane-Tazobactam against Burkholderia pseudomalleiANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)Chan, ElaineMartelli, PaoloHui, Suk-WaiTeng, Jade L. L.Lau, Susanna K. P.Woo, Patrick C. Y.
- [26] First Study of Antimicrobial Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infection in Tehran, IranINFECTION AND DRUG RESISTANCE, 2020, 13 : 533 - 541Rahimzadeh, MohammadHabibi, MehriBouzari, SaeidKaram, Mohammad Reza Asadi
- [27] Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam ResistanceCLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4599 - E4606Tamma, Pranita D.Beisken, StephanBergman, YehuditPosch, Andreas E.Avdic, EdinaSharara, Sima L.Cosgrove, Sara E.Simner, Patricia J.
- [28] Ceftolozane-Tazobactam utilization in the national veterans affairs healthcare systemPHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 508 - 509Cusumano, Jaclyn A.Bodo, EmilyLopes, VrishaliMcConeghy, Kevin W.Puzniak, Laura A.McCann, EilishLaPlante, Kerry L.Caffrey, Aisling R.
- [29] Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of EnterobacteralesJOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 32 : 78 - 84Jousset, Agnes B.Bernabeu, SandrineEmeraud, CecileBonnin, Remy A.Lomont, AlexandraZahar, Jean RalphMerens, AudreyIsnard, ChristopheSoismier, NathalieFarfour, EricFihman, VincentYin, NicolasBarraud, OlivierJacquier, HerveRanc, Anne-GaelleLaurent, FredericCorvec, Stephaned'Epenoux, Louise RuffierBille, EmmanuelleDegand, NicolasPlouzeau, ChloeGuillard, ThomasCattoir, VincentMizrahi, AsafGrillon, AntoineJanvier, FredericLe Brun, CecileAmara, MarleneBastide, MathildaLemonnier, AlbanDortet, Laurent
- [30] Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infectionJOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (03) : 182 - 191Kakara, MakotoLarson, KajalFeng, Hwa-pingShiomi, MariYoshitsugu, HiroyukiRizk, Matthew L.